vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与XPEL, Inc.（XPEL）财务数据对比。点击上方公司名可切换其他公司
XPEL, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.6倍（$122.3M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 13.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $1.6M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 16.5%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
XPEL是全球知名的高性能表面保护膜解决方案供应商，核心产品涵盖汽车漆面保护膜、车窗隔热膜、陶瓷涂层等，业务覆盖北美、欧洲、亚太等主要市场，服务对象包括普通车主、汽车经销商及专业安装服务商。
PBYI vs XPEL — 直观对比
营收规模更大
XPEL
是对方的1.6倍
$75.5M
营收增速更快
PBYI
高出14.0%
13.7%
自由现金流更多
PBYI
多$12.8M
$1.6M
两年增速更快
PBYI
近两年复合增速
16.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $122.3M |
| 净利润 | — | $13.4M |
| 毛利率 | 69.3% | 41.9% |
| 营业利润率 | 22.7% | 12.7% |
| 净利率 | — | 11.0% |
| 营收同比 | 27.7% | 13.7% |
| 净利润同比 | — | 50.7% |
| 每股收益（稀释后） | $0.26 | $0.48 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIXPEL
| Q4 25 | $75.5M | $122.3M | ||
| Q3 25 | $54.5M | $125.4M | ||
| Q2 25 | $52.4M | $124.7M | ||
| Q1 25 | $46.0M | $103.8M | ||
| Q4 24 | $59.1M | $107.5M | ||
| Q3 24 | $80.5M | $112.9M | ||
| Q2 24 | $47.1M | $109.9M | ||
| Q1 24 | $43.8M | $90.1M |
净利润PBYIXPEL
| Q4 25 | — | $13.4M | ||
| Q3 25 | $8.8M | $12.9M | ||
| Q2 25 | $5.9M | $16.3M | ||
| Q1 25 | $3.0M | $8.6M | ||
| Q4 24 | — | $8.9M | ||
| Q3 24 | $20.3M | $14.9M | ||
| Q2 24 | $-4.5M | $15.0M | ||
| Q1 24 | $-4.8M | $6.7M |
毛利率PBYIXPEL
| Q4 25 | 69.3% | 41.9% | ||
| Q3 25 | 77.7% | 41.8% | ||
| Q2 25 | 76.5% | 42.9% | ||
| Q1 25 | 77.1% | 42.3% | ||
| Q4 24 | 76.4% | 40.6% | ||
| Q3 24 | 63.9% | 42.5% | ||
| Q2 24 | 77.4% | 43.5% | ||
| Q1 24 | 75.5% | 42.0% |
营业利润率PBYIXPEL
| Q4 25 | 22.7% | 12.7% | ||
| Q3 25 | 17.6% | 13.4% | ||
| Q2 25 | 12.7% | 15.5% | ||
| Q1 25 | 8.7% | 10.7% | ||
| Q4 24 | 22.6% | 11.5% | ||
| Q3 24 | 27.4% | 16.3% | ||
| Q2 24 | -4.6% | 17.5% | ||
| Q1 24 | -5.3% | 10.2% |
净利率PBYIXPEL
| Q4 25 | — | 11.0% | ||
| Q3 25 | 16.2% | 10.3% | ||
| Q2 25 | 11.2% | 13.1% | ||
| Q1 25 | 6.5% | 8.3% | ||
| Q4 24 | — | 8.3% | ||
| Q3 24 | 25.2% | 13.2% | ||
| Q2 24 | -9.6% | 13.7% | ||
| Q1 24 | -11.0% | 7.4% |
每股收益（稀释后）PBYIXPEL
| Q4 25 | $0.26 | $0.48 | ||
| Q3 25 | $0.17 | $0.47 | ||
| Q2 25 | $0.12 | $0.59 | ||
| Q1 25 | $0.06 | $0.31 | ||
| Q4 24 | $0.40 | $0.33 | ||
| Q3 24 | $0.41 | $0.54 | ||
| Q2 24 | $-0.09 | $0.54 | ||
| Q1 24 | $-0.10 | $0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $50.9M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $280.3M |
| 总资产 | $216.3M | $382.5M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIXPEL
| Q4 25 | $97.5M | $50.9M | ||
| Q3 25 | $94.4M | $64.5M | ||
| Q2 25 | $96.0M | $49.6M | ||
| Q1 25 | $93.2M | $23.5M | ||
| Q4 24 | $101.0M | $22.1M | ||
| Q3 24 | $96.7M | $21.0M | ||
| Q2 24 | $96.8M | $15.0M | ||
| Q1 24 | $107.2M | $8.6M |
总债务PBYIXPEL
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIXPEL
| Q4 25 | $130.3M | $280.3M | ||
| Q3 25 | $115.3M | $269.3M | ||
| Q2 25 | $104.7M | $255.7M | ||
| Q1 25 | $97.1M | $235.5M | ||
| Q4 24 | $92.1M | $225.5M | ||
| Q3 24 | $71.1M | $218.7M | ||
| Q2 24 | $48.5M | $201.9M | ||
| Q1 24 | $51.0M | $186.4M |
总资产PBYIXPEL
| Q4 25 | $216.3M | $382.5M | ||
| Q3 25 | $202.9M | $387.7M | ||
| Q2 25 | $194.9M | $318.1M | ||
| Q1 25 | $196.2M | $294.8M | ||
| Q4 24 | $213.3M | $285.6M | ||
| Q3 24 | $220.7M | $273.0M | ||
| Q2 24 | $205.0M | $261.8M | ||
| Q1 24 | $214.1M | $258.5M |
负债/权益比PBYIXPEL
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $2.7M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $1.6M |
| 自由现金流率自由现金流/营收 | 19.1% | 1.3% |
| 资本支出强度资本支出/营收 | 0.0% | 0.9% |
| 现金转化率经营现金流/净利润 | — | 0.20× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $62.9M |
8季度趋势，按日历期对齐
经营现金流PBYIXPEL
| Q4 25 | $14.4M | $2.7M | ||
| Q3 25 | $9.7M | $33.2M | ||
| Q2 25 | $14.1M | $27.9M | ||
| Q1 25 | $3.6M | $3.2M | ||
| Q4 24 | $15.6M | $6.3M | ||
| Q3 24 | $11.0M | $19.6M | ||
| Q2 24 | $1.0M | $26.9M | ||
| Q1 24 | $11.2M | $-5.0M |
自由现金流PBYIXPEL
| Q4 25 | $14.4M | $1.6M | ||
| Q3 25 | $9.7M | $32.2M | ||
| Q2 25 | $14.1M | $26.9M | ||
| Q1 25 | $3.6M | $2.2M | ||
| Q4 24 | $15.6M | $4.7M | ||
| Q3 24 | $11.0M | $18.3M | ||
| Q2 24 | $1.0M | $25.1M | ||
| Q1 24 | — | $-7.0M |
自由现金流率PBYIXPEL
| Q4 25 | 19.1% | 1.3% | ||
| Q3 25 | 17.7% | 25.6% | ||
| Q2 25 | 26.8% | 21.6% | ||
| Q1 25 | 7.7% | 2.1% | ||
| Q4 24 | 26.4% | 4.4% | ||
| Q3 24 | 13.7% | 16.2% | ||
| Q2 24 | 2.1% | 22.8% | ||
| Q1 24 | — | -7.7% |
资本支出强度PBYIXPEL
| Q4 25 | 0.0% | 0.9% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 0.1% | 1.0% | ||
| Q4 24 | 0.0% | 1.5% | ||
| Q3 24 | 0.0% | 1.1% | ||
| Q2 24 | 0.0% | 1.6% | ||
| Q1 24 | 0.0% | 2.2% |
现金转化率PBYIXPEL
| Q4 25 | — | 0.20× | ||
| Q3 25 | 1.10× | 2.56× | ||
| Q2 25 | 2.41× | 1.71× | ||
| Q1 25 | 1.21× | 0.38× | ||
| Q4 24 | — | 0.71× | ||
| Q3 24 | 0.54× | 1.31× | ||
| Q2 24 | — | 1.79× | ||
| Q1 24 | — | -0.74× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
XPEL
| Products | $90.9M | 74% |
| Service Revenue Installation Labor | $23.8M | 19% |
| Service Revenue Cutbank Credits | $4.1M | 3% |
| Service Revenue Software | $2.2M | 2% |
